Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks
Authors:
- Albert L. ShefferASAlbert L. Sheffer
- Andrew J. MacGinnitieAMAndrew J. MacGinnitie
- Marilyn CampionMCMarilyn Campion
- Leslie E. StolzLSLeslie E. Stolz
- William E. PullmanWPWilliam E. Pullman
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 110 (3) , 184-188.e2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiencyJournal of Allergy and Clinical Immunology, 2012
- The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depressionAllergy and Asthma Proceedings, 2010
- Economic costs associated with acute attacks and long-term management of hereditary angioedemaAnnals of Allergy, Asthma & Immunology, 2010
- The bradykinin-forming cascade and its role in hereditary angioedemaAnnals of Allergy, Asthma & Immunology, 2010
- Hereditary AngioedemaNew England Journal of Medicine, 2008
- Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and CourseThe American Journal of Medicine, 2006
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- Clinical Studies of Sudden Upper Airway Obstruction in Patients With Hereditary Angioedema Due to C1 Esterase Inhibitor DeficiencyArchives of internal medicine (1960), 2003
- Asphyxiation by Laryngeal Edema in Patients With Hereditary AngioedemaMayo Clinic Proceedings, 2000
- Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.Proceedings of the National Academy of Sciences, 1986